- Report
- January 2024
- 116 Pages
Global
From €3500EUR$3,941USD£3,086GBP
- Report
- February 2024
- 132 Pages
Global
From €904EUR$950USD£770GBP
- Report
- September 2023
- 200 Pages
Global
From €2331EUR$2,450USD£1,986GBP
- Report
- October 2022
- 310 Pages
Global
From €3654EUR$3,840USD£3,112GBP
- Report
- December 2021
- 136 Pages
Global
From €4281EUR$4,500USD£3,647GBP
The High Potency API (HPAI) market is a subset of the pharmaceutical intermediates market, focusing on the production of active pharmaceutical ingredients (APIs) with high potency. These APIs are used in the manufacture of drugs and other pharmaceutical products, and are typically produced in small quantities due to their potency. HPAI production requires specialized equipment and processes, as well as stringent safety protocols, to ensure the safety of workers and the environment.
HPAI production is a complex process, involving multiple steps such as synthesis, purification, and formulation. The production of HPAI is highly regulated, and manufacturers must adhere to strict quality standards to ensure the safety and efficacy of their products.
Companies in the HPAI market include Lonza, Boehringer Ingelheim, Dr. Reddy's Laboratories, and Aurobindo Pharma. Show Less Read more